INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.85 Million USD | -29.36% |
| 2022 | 11.11 Million USD | 20.43% |
| 2021 | 9.23 Million USD | 42.83% |
| 2020 | 6.46 Million USD | 106.59% |
| 2019 | 3.12 Million USD | 2.98% |
| 2018 | 3.03 Million USD | 248.96% |
| 2017 | 870.61 Thousand USD | -59.44% |
| 2016 | 2.14 Million USD | 258.33% |
| 2015 | 598.95 Thousand USD | -64.55% |
| 2014 | 1.68 Million USD | 171.75% |
| 2013 | 621.71 Thousand USD | 5.77% |
| 2012 | 587.79 Thousand USD | -22.32% |
| 2011 | 756.71 Thousand USD | -51.53% |
| 2010 | 1.56 Million USD | -16.27% |
| 2009 | 1.86 Million USD | -1.31% |
| 2008 | 1.88 Million USD | 4246.77% |
| 2007 | 43.46 Thousand USD | 471.77% |
| 2006 | 7602.00 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.44 Million USD | -27.85% |
| 2024 Q2 | 2.64 Million USD | 83.16% |
| 2023 Q4 | 2 Million USD | 56.49% |
| 2023 Q1 | 2.58 Million USD | -11.5% |
| 2023 Q2 | 2.12 Million USD | -17.64% |
| 2023 FY | 7.85 Million USD | -29.36% |
| 2023 Q3 | 1.28 Million USD | -39.8% |
| 2022 Q3 | 2.65 Million USD | 0.62% |
| 2022 FY | 11.11 Million USD | 20.43% |
| 2022 Q4 | 2.91 Million USD | 10.02% |
| 2022 Q1 | 2.79 Million USD | 12.06% |
| 2022 Q2 | 2.63 Million USD | -5.83% |
| 2021 Q2 | 2.08 Million USD | -4.64% |
| 2021 Q3 | 2.47 Million USD | 18.83% |
| 2021 FY | 9.23 Million USD | 42.83% |
| 2021 Q4 | 2.49 Million USD | 1.02% |
| 2021 Q1 | 2.18 Million USD | 10.51% |
| 2020 FY | 6.46 Million USD | 106.59% |
| 2020 Q3 | 1.57 Million USD | 22.41% |
| 2020 Q4 | 1.97 Million USD | 25.23% |
| 2020 Q2 | 1.28 Million USD | -20.75% |
| 2020 Q1 | 1.62 Million USD | 56.12% |
| 2019 FY | 3.12 Million USD | 2.98% |
| 2019 Q2 | 669.15 Thousand USD | 26.84% |
| 2019 Q1 | 527.56 Thousand USD | -15.53% |
| 2019 Q3 | 891 Thousand USD | 33.15% |
| 2019 Q4 | 1.04 Million USD | 16.82% |
| 2018 Q3 | 299.54 Thousand USD | -84.1% |
| 2018 FY | 3.03 Million USD | 248.96% |
| 2018 Q1 | 229.99 Thousand USD | -13.95% |
| 2018 Q4 | 624.57 Thousand USD | 108.51% |
| 2018 Q2 | 1.88 Million USD | 719.11% |
| 2017 Q4 | 267.27 Thousand USD | 33.84% |
| 2017 FY | 870.61 Thousand USD | -59.44% |
| 2017 Q3 | 199.69 Thousand USD | 0.58% |
| 2017 Q2 | 198.54 Thousand USD | -3.19% |
| 2017 Q1 | 205.09 Thousand USD | -25.88% |
| 2016 FY | 2.14 Million USD | 258.33% |
| 2016 Q4 | 276.71 Thousand USD | 26.5% |
| 2016 Q3 | 218.74 Thousand USD | -84.97% |
| 2016 Q2 | 1.45 Million USD | 643.92% |
| 2016 Q1 | 195.6 Thousand USD | -16.89% |
| 2015 Q4 | 235.37 Thousand USD | 101.4% |
| 2015 Q3 | 116.86 Thousand USD | 3.0% |
| 2015 Q1 | 133.26 Thousand USD | 0.0% |
| 2015 Q2 | 113.45 Thousand USD | -14.86% |
| 2015 FY | 598.95 Thousand USD | -64.55% |
| 2014 FY | 1.68 Million USD | 171.75% |
| 2013 FY | 621.71 Thousand USD | 5.77% |
| 2012 FY | 587.79 Thousand USD | -22.32% |
| 2011 Q1 | 200.95 Thousand USD | -53.67% |
| 2011 Q2 | 220.02 Thousand USD | 9.49% |
| 2011 Q3 | 182.1 Thousand USD | -17.23% |
| 2011 Q4 | 154.09 Thousand USD | -15.38% |
| 2011 FY | 756.71 Thousand USD | -51.53% |
| 2010 FY | 1.56 Million USD | -16.27% |
| 2010 Q1 | 446.62 Thousand USD | -3.95% |
| 2010 Q4 | 433.7 Thousand USD | 19.39% |
| 2010 Q2 | 317.59 Thousand USD | -28.89% |
| 2010 Q3 | 363.27 Thousand USD | 14.38% |
| 2009 Q3 | 293.58 Thousand USD | -33.89% |
| 2009 Q1 | 661.85 Thousand USD | -64.2% |
| 2009 FY | 1.86 Million USD | -1.31% |
| 2009 Q4 | 465.01 Thousand USD | 58.39% |
| 2009 Q2 | 444.1 Thousand USD | -32.9% |
| 2008 Q3 | 13.16 Thousand USD | 38.32% |
| 2008 Q2 | 9520.00 USD | -46.61% |
| 2008 Q1 | 17.83 Thousand USD | -8.85% |
| 2008 Q4 | 1.84 Million USD | 13940.46% |
| 2008 FY | 1.88 Million USD | 4246.77% |
| 2007 FY | 43.46 Thousand USD | 471.77% |
| 2007 Q4 | 19.56 Thousand USD | 154.75% |
| 2007 Q2 | 13 Thousand USD | 303.1% |
| 2007 Q1 | 3225.00 USD | 0.0% |
| 2007 Q3 | 7679.00 USD | -40.93% |
| 2006 FY | 7602.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 30.031% |
| Cerus Corporation | 143.15 Million USD | 94.514% |
| OrthoPediatrics Corp. | 137.01 Million USD | 94.268% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 30.874% |
| Talis Biomedical Corporation | 67.18 Million USD | 88.311% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 68.519% |
| Inogen, Inc. | 236.08 Million USD | 96.674% |
| Spectral AI, Inc. | 20.86 Million USD | 62.36% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 85.976% |
| CVRx, Inc. | 76.14 Million USD | 89.686% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -122.599% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 37.118% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.823% |
| Venus Concept Inc. | 80.47 Million USD | 90.241% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 86.12% |
| Bioventus Inc. | 409.91 Million USD | 98.084% |
| BrainsWay Ltd. | 28.01 Million USD | 71.971% |
| Envoy Medical, Inc. | 17.89 Million USD | 56.122% |
| electroCore, Inc. | 32.03 Million USD | 75.482% |
| IceCure Medical Ltd | 16.87 Million USD | 53.465% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 81.492% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 55.463% |
| MaxCyte, Inc. | 84.84 Million USD | 90.744% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 36.727% |
| Nexalin Technology, Inc. | 5.78 Million USD | -35.838% |
| PAVmed Inc | 64.82 Million USD | 87.886% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 84.625% |
| RxSight, Inc. | 103.85 Million USD | 92.438% |
| Sight Sciences, Inc. | 126.44 Million USD | 93.789% |
| SI-BONE, Inc. | 156.35 Million USD | 94.977% |
| TELA Bio, Inc. | 84.18 Million USD | 90.672% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 88.79% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 96.138% |
| LivaNova PLC | 843.54 Million USD | 99.069% |
| 908 Devices Inc. | 68.08 Million USD | 88.465% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 98.376% |
| Nemaura Medical Inc. | 7.13 Million USD | -10.009% |
| NeuroPace, Inc. | 75.29 Million USD | 89.57% |
| LENSAR, Inc. | 33.33 Million USD | 76.442% |
| Apyx Medical Corporation | 51.01 Million USD | 84.607% |
| Cutera, Inc. | 197.72 Million USD | 96.028% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 68.309% |
| BioSig Technologies, Inc. | 28.53 Million USD | 72.474% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 95.899% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 78.222% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 99.061% |
| Axonics, Inc. | 270.2 Million USD | 97.094% |
| Outset Medical, Inc. | 198.77 Million USD | 96.049% |
| IRIDEX Corporation | 31.81 Million USD | 75.315% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 95.642% |
| IRadimed Corporation | 30.12 Million USD | 73.929% |
| Tivic Health Systems, Inc. | 8.53 Million USD | 7.955% |
| Telesis Bio, Inc. | 63.48 Million USD | 87.63% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 92.023% |
| Varex Imaging Corporation | 224.8 Million USD | 96.507% |
| Quipt Home Medical Corp. | 148.66 Million USD | 94.718% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 33.01% |
| Pulmonx Corporation | 112.68 Million USD | 93.031% |
| Dynatronics Corporation | 9.9 Million USD | 20.738% |
| Modular Medical, Inc. | 17.52 Million USD | 55.198% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 61.097% |
| Semler Scientific, Inc. | 38.94 Million USD | 79.834% |
| InMode Ltd. | 215.68 Million USD | 96.359% |
| Bruker Corporation | 1.07 Billion USD | 99.27% |
| Cytosorbents Corporation | 48.33 Million USD | 83.753% |
| DexCom, Inc. | 1.69 Billion USD | 99.536% |
| Align Technology, Inc. | 2.07 Billion USD | 99.622% |
| Viveve Medical, Inc. | 22.17 Million USD | 64.582% |
| ZimVie Inc. | 275.12 Million USD | 97.146% |
| Movano Inc. | 29.69 Million USD | 73.549% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 94.279% |
| Nexalin Technology, Inc. | 5.78 Million USD | -35.838% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -122.599% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.693% |
| Profound Medical Corp. | 33.6 Million USD | 76.629% |
| Insulet Corporation | 939.9 Million USD | 99.164% |
| enVVeno Medical Corporation | 25.23 Million USD | 68.883% |
| Surmodics, Inc. | 98.69 Million USD | 92.043% |
| iCAD, Inc. | 22.22 Million USD | 64.665% |
| Nuwellis, Inc. | 22.61 Million USD | 65.271% |
| Biotricity, Inc. | 17.18 Million USD | 54.3% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 98.239% |
| Aethlon Medical, Inc. | 12.27 Million USD | 36.035% |
| InspireMD, Inc. | 22.95 Million USD | 65.781% |
| PAVmed Inc. | 64.82 Million USD | 87.886% |
| BIOLASE, Inc. | 34.66 Million USD | 77.343% |
| Beyond Air, Inc. | 61.7 Million USD | 87.272% |
| FONAR Corporation | 28.6 Million USD | 72.545% |
| AxoGen, Inc. | 149.33 Million USD | 94.741% |
| Vivani Medical, Inc. | 26.96 Million USD | 70.876% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 95.565% |
| Inari Medical, Inc. | 448.59 Million USD | 98.249% |
| UFP Technologies, Inc. | 58.08 Million USD | 86.481% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -59.374% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -24.295% |
| Tenon Medical, Inc. | 16.96 Million USD | 53.717% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -6.226% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 82.193% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.271% |
| Sintx Technologies, Inc. | 15.2 Million USD | 48.337% |
| NanoVibronix, Inc. | 4.97 Million USD | -57.919% |
| Quanterix Corporation | 118.1 Million USD | 93.35% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 33.01% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 45.622% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 98.0% |
| TransMedics Group, Inc. | 182.82 Million USD | 95.704% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 72.017% |
| NeuroMetrix, Inc. | 11.09 Million USD | 29.243% |
| Hyperfine, Inc. | 52.87 Million USD | 85.147% |
| Establishment Labs Holdings Inc. | 172 Million USD | 95.434% |
| Biomerica, Inc. | 6.97 Million USD | -12.544% |
| Bone Biologics Corporation | 9.42 Million USD | 16.705% |
| AVITA Medical, Inc. | 80.77 Million USD | 90.278% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 23.837% |
| Silk Road Medical, Inc | 186.35 Million USD | 95.786% |